References

• 2002Mortality Associated With Sleep Duration and Insomnia1,614 cited
• 2005Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits1,158 cited
• 2009The Economic Burden of Insomnia: Direct and Indirect Costs for Individuals with Insomnia Syndrome, Insomnia Symptoms, and Good Sleepers664 cited
• 1997Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders423 cited
• 1999Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.397 cited
• 2003Insomnia: Epidemiology, characteristics, and consequences359 cited
• 2000Zolpidem317 cited
• 2012Zolpidem for insomnia284 cited
• 2004Residual Effects of Hypnotics278 cited
• 2007Prolonged‐release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects261 cited
• 2010Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety178 cited
• 1992Prevalence of self-reported poor sleep in a healthy population aged 50–65162 cited
• 2009The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia136 cited